Supplement Evidence LabHealth supplement claims, read together with the actual research

Spermidine: the "longevity nutrient" marketing vs. what the trial measured

Human evidence: C (strong observational data, negative RCT primary outcome) Updated: October 2026

Summary: Observational studies consistently link spermidine-rich diets to lower mortality across two independent cohorts. But the largest randomized trial of a spermidine supplement (SmartAge, 100 older adults, 12 months) failed its primary memory outcome. "A nutrient in traditional diets" and "an effective capsule" are, at present, different claims.

What is claimed

Spermidine is a polyamine found in natto, miso, rice bran pickles, whole grains, and vegetables. It induces autophagy in animal models, extends lifespan in mice, and some researchers call it an "anti-aging vitamin." It has become one of the fastest-growing anti-aging supplements in Japan.

What has actually been shown

1. Cohort data: a strong link with lower mortality (Brune study, 2018)

In an Austrian cohort of 829 adults (45–84) followed ~20 years, all-cause mortality fell from 40.5 to 15.1 per 1,000 person-years between the lowest and highest thirds of dietary spermidine intake. Adjusted hazard ratio per 1-SD higher intake: 0.74 (95% CI 0.66–0.83); fully adjusted 0.76 (0.67–0.86). Replicated in an independent cohort (SAPHIR, 1,770 participants): HR 0.71 (0.53–0.95). The authors estimate the top-vs-bottom difference is comparable to being 5.7 years younger. The Japanese Takayama study (2023) found similar directionality for dietary polyamines and ischemic heart disease mortality.

These are observational studies. A spermidine-rich diet is also a vegetable-, legume-, and whole-grain-rich diet; the effect of the whole pattern cannot be cleanly attributed to spermidine alone.

2. Supplement RCT: the biggest trial is negative on its primary outcome (SmartAge, 2022)

A 12-month double-blind placebo-controlled trial (100 adults aged 60–90 with subjective cognitive decline; wheat-germ extract, 0.9 mg/day) found a between-group difference in mnemonic discrimination of −0.03 (95% CI −0.11 to 0.05; p=0.47) — no significant effect. Secondary cognitive and physiological outcomes were also null overall. Exploratory analyses hinted at anti-inflammatory (sICAM-1) and verbal-memory signals; the authors themselves call for higher-dose trials. An earlier small pilot (30 people, 3 months, 2018) had shown a positive memory effect that SmartAge did not reproduce.

3. The dose gap

Cohort participants ate roughly 10 mg/day of spermidine from food. The SmartAge capsule delivered 0.9 mg/day (about a 10% increase over diet). The cohort numbers and the trial dose differ by more than an order of magnitude — so a negative trial does not yet refute spermidine itself. That gap is the honest current state of this field.

Weaknesses & cautions

Bottom line

Eating a spermidine-rich diet (natto, miso, pickled rice bran, whole grains, vegetables) has strong observational support. Taking a spermidine capsule for anti-aging is currently rated C: promising, unproven, with the largest trial negative. Food first; capsules only with verified dose and standardization.

Sources

  1. Kiechl S et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr 108:371–380 (2018). PMID 29955838
  2. Schwarz C et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial (SmartAge). JAMA Netw Open 5(5):e2213875 (2022). PMID 35616942
  3. Wirth M et al. The effect of spermidine on memory performance in older adults at risk for dementia: a randomized controlled trial. Cortex 109:181–188 (2018). PMID 30388439
  4. Nagata C et al. Dietary polyamine intake and all-cause and cause-specific mortality in Japanese adults in the Takayama study. Br J Nutr 131:343–350 (2023). PMID 37964604

Informational content only — not medical advice. Consult a clinician if you have a medical condition or take medications.